Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Net Income: 2015-2025

Historic Net Income for Wave Life Sciences (WVE) over the last 11 years, with Sep 2025 value amounting to -$53.9 million.

  • Wave Life Sciences' Net Income rose 12.83% to -$53.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$121.9 million, marking a year-over-year increase of 14.45%. This contributed to the annual value of -$97.0 million for FY2024, which is 68.67% down from last year.
  • Latest data reveals that Wave Life Sciences reported Net Income of -$53.9 million as of Q3 2025, which was down 6.70% from -$50.5 million recorded in Q2 2025.
  • In the past 5 years, Wave Life Sciences' Net Income ranged from a high of $29.3 million in Q4 2024 and a low of -$61.8 million during Q3 2024.
  • For the 3-year period, Wave Life Sciences' Net Income averaged around -$27.8 million, with its median value being -$31.6 million (2024).
  • The largest annual percentage gain for Wave Life Sciences' Net Income in the last 5 years was 279.70% (2024), contrasted with its biggest fall of 949.21% (2024).
  • Wave Life Sciences' Net Income (Quarterly) stood at -$34.8 million in 2021, then decreased by 25.65% to -$43.7 million in 2022, then skyrocketed by 62.76% to -$16.3 million in 2023, then soared by 279.70% to $29.3 million in 2024, then grew by 12.83% to -$53.9 million in 2025.
  • Its last three reported values are -$53.9 million in Q3 2025, -$50.5 million for Q2 2025, and -$46.9 million during Q1 2025.